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Abstract   
Background  Intramural metastasis in gastric cancer is rare. However, it often occurs 
with esophageal squamous cell carcinoma and has been reported to have a poor 
prognosis. 
Methods  In 4714 cases of gastric cancer that underwent gastrectomy, the 
clinicopathological features and postoperative prognoses of 29 cases with intramural 
metastasis were evaluated and compared with 2770 cases of advanced gastric cancer 
without intramural metastasis.  
Results  Of the 4714 cases, 29 (0.6 %) were histopathologically diagnosed with gastric 
cancer with intramural metastasis. There were significant differences in the number of 
lymph node metastases, capillary invasion and stage grouping between cases with 
intramural metastasis and advanced gastric cancer without intramural metastasis. 
Metastasis size was approximately within 2 cm, and many occurred within 2 cm of the 
primary lesion. Multiple metastases were observed in 38 % of cases. and occurred 
mainly in the submucosa and muscularis propria. Intramural metastasis was detected 
preoperatively in 17.2% of cases and was present equally on both sides of the primary 
lesion. Nine cases had intramural metastasis outside the stomach. The median survival 
time with intramural metastasis was significantly lower than in cases of advanced 
gastric cancer without intramural metastasis (p < 0.0001). A subgroup of cases with 
intramural metastasis within 1 cm of the primary lesion had a relatively favorable 
prognosis. 
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Conclusions  The presence of intramural metastasis is thought to be one of the most 
important prognostic factors in gastric cancer. Aggressive resection is recommended to 
increase long-term survival if curative resection is possible. 
 
Mini abstract 
One percent of advanced gastric cancer cases had intramural metastasis and a poor 
prognosis. However, long-term survival was obtained when complete curability was 
achieved. Aggressive resection is, therefore, recommended. 
 
Keywords Stomach Neoplasms • Gastric cancer • Lymphatic metastasis • Intramural 
metastasis • Prognosis 
4 
 
Introduction 
Intramural metastasis (IM) in gastric cancer has been rarely reported; however, 
esophageal squamous cell carcinoma is often accompanied by IM and such cases have 
been reported to have a poor prognosis. As a result, the presence of IM with carcinoma 
is considered to be one of the most important prognostic factors [1–3]. There have been 
no detailed clinicopathologic descriptions of IM in gastric cancer, to date. Therefore, we 
retrospectively conducted a clinicopathological study on the incidence of IM and its 
relationship to prognosis and survival. 
 
Patients and Methods 
We reviewed 29 cases with IM in gastric cancer among 4714 cases (0.6 %) that 
underwent gastrectomy between 1975 and 2004 at the Tokyo Metropolitan Cancer and 
Infectious Diseases Center, Komagome Hospital: CICK. Clinicopathological 
characteristics including age, gender, operation data, histological diagnosis, stage and 
survival data were obtained from our hospital database and clinical records. 
Preoperative diagnosis was based on upper gastrointestinal barium studies, endoscopic 
examination and computed tomography. Resected specimens were examined using 
standard hematoxylin-eosin staining. The gastric cancers were evaluated according to 
the Japanese Gastric Cancer Association, 3rd English edition, Japanese classification of 
gastric carcinoma [4]. 
Diagnostic criteria of IM 
To diagnose IM histologically, we modified the criteria of Nishimaki et al. [1] as 
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follows: (1) clearly separated from the primary tumor; (2) located in the esophageal, 
stomach or duodenal wall; (3) having a gross appearance of a submucosal tumor 
without intraepithelial cancer extension; (4) having the same histological type as the 
primary tumor; and (5) lacking any evidence of intravascular growth. 
 These criteria discriminated IMs from multiple primary tumors in the 
esophagus or stomach and from intravascular tumor emboli around the primary tumor. A 
typical example of IM is shown in Fig. 1. 
Statistical analysis 
The association between factors was evaluated using the χ2 test and fisher’s exact 
probability test. The significance of difference among means was determined using the 
Mann-Whitney U-test. Survival rates were determined using the Kaplan-Meier method, 
and differences between survival curves were examined with the log-rank test. 
Statistical analyses were performed using the SAS software package Stat View, version 
5.0 (SAS Institute, NC, USA). A result was considered statistically significant when the 
P value was < 0.05. 
 
Results 
From 1975 to 2004, 4714 patients with gastric cancers underwent gastrectomy at the 
CICK. Surgeries were as follows: 1691 cases of total gastrectomy; 2721 cases of distal 
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gastrectomy; 162 cases of proximal gastrectomy; 94 cases of segmentectomy; 11 cases 
of pancreaticoduodenectomy; 32 cases of pylorus-preserving gastrectomy; and 3 cases 
of segmental resection of the stomach. There were 1915 cases of early cancer and 2799 
cases of advanced cancer. All 29 cases of IM were seen in advanced cancers providing 
an onset frequency of 0.6 % of all resection cases, and 1 % of advanced cancer cases. In 
IM cases, surgeries were as follows: 17 cases of total gastrectomy; 11 cases of distal 
gastrectomy; and 1 case of proximal gastrectomy. 
 
The clinicopathological characteristics of gastric cancer with IM 
To evaluate the clinicopathological characteristics of gastric cancer with IM, 29 cases of 
gastric cancer with IM were compared with 2770 cases of advanced gastric cancer 
without IM (Table 1). The mean age of IM cases is higher than cases of advanced 
gastric cancer without IM. Histologically, IM cases occurred significant more frequently 
in the number of lymph node metastases, lymphatic invasion, vessel invasion and 
advanced stage grouping compared with cases of advanced gastric cancer without IM. 
All IM cases showed marked lymph node metastasis and capillary invasion. There were 
no significant difference these two groups with respect to gender, the main location of 
the primary tumor, tumor size, macroscopic type, histologic type, depth of invasion and 
residual tumor.  
 
Characteristics of IM 
The characteristics of IM are shown in Table 2. The mean IM size was 1.09 ± 1.10 cm 
(range: 0.2–6.0 cm). The number of IMs was one in 18 cases (62%), two in 4 cases, 
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three in 4 cases, four in 1 case, and five or more in 2 cases (multiple: 38%). The layers 
affected by IM were: 13 cases (45 %) in the submucosa (sm); 10 cases (34 %) in the 
muscularis propria (mp); 5 cases (17 %) in the subserosa (ss); and 1 (4 %) case in the 
serosa exposed (se). IM was detected preoperatively in 5 cases (17.2 %) using upper 
gastrointestinal barium studies and endoscopic examination. The mean distance between 
the IM and the primary tumor was 1.21 ± 0.94 cm (range: 0.1– 5.5 cm). Eleven cases 
had IM in the portion of the surgical specimen proximal to the primary tumor, 11 cases 
had IM in the distal portion, and 7 cases had IM on both sides. Nine cases had IM in an 
adjacent organ, six cases had IM in the esophageal wall and 3 cases had IM in the 
duodenal wall.  
 
Prognosis of the IM cases 
The median survival time for all gastric cancers with IM was 11 months (with a 13.9 % 
survival rate at 3 years). Survival time was 13.5 months (with an 18.8 % survival rate at 
3 years) for cases in which R0 resection was obtained, and 7.5 months (with an 8.9 % 
survival rate at 3 years) for cases in which R1/2 resection was obtained, with no 
significant difference observed between the two groups (p = 0.12) (Fig. 2). However, no 
cases of recurrence were observed in 5 of 14 cases in which R0 resection was obtained. 
The median survival time for all gastric cancers with IM was significantly lower than 
for cases of advanced gastric cancer without IM (p < 0.0001). In cases of advanced 
gastric cancer without IM, the median survival time was 39.4 months with a 51.1 % 
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survival rate at 3 years (Fig. 3). 
 Prognosis by distance from the primary lesion and by the size of the IM was 
also calculated. The relationship between the size of the IM and the distance from the 
primary lesion is shown in Fig. 4. A constant tendency was not observed between the 
IM size and the distance from the primary lesion, but the IM size was approximately 
within 2 cm, and many occurred within 2 cm of the primary lesion. So, when the cutoff 
value for the distance was set at various lengths from 0.5 cm to 2 cm, the 1 cm distance 
was associated with the most significant difference in survival. Cases with a distance 
from the primary tumor of less than 1 cm lived significantly longer than cases with a 
distance of 1 cm or more from the primary tumor. In all cases of IM for the distance 
from the primary tumor, 3-year survival rates and median survival times were 25.7 % 
and 28 months vs. 0 % and 8 months (p = 0.0026), respectively. In R0 cases of IM for 
the distance from the primary tumor, 3-year survival rates and median survival times 
were 41.7 % and 29 months vs. 0 % and 11 months, respectively (p = 0.0075) (Fig 5). 
 Three-year survival rates and median survival times of cases with an IM size 
smaller than 1 cm were higher than cases with IMs of 1 cm or larger, although the 
difference was not significant. In all cases of IM for the IM size, 3-year survival rates 
and median survival times were 22.1 % and 13 months vs. 0 % and 9 months, 
respectively (p = 0.36). In R0 cases of IM for IM size, 3-year survival rates and median 
survival times were 20.0 % and 14.5 months vs. not assessable and 11.5 months, 
respectively (p = 0.72) (Fig 6). 
  
Discussion 
Generally, IM in gastric adenocarcinoma is very rare. A PubMed search from 1950 to 
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2010 using gastric cancer and intramural metastasis as key words, revealed only three 
case reports [5, 6], and there are no articles to date that have verified this condition. This 
study provided the first analysis of IM in gastric cancer. 
 Contrary to IM in gastric cancer, IM is often observed in esophageal squamous 
cell carcinoma and was first reported by Watson et al. [7] in 1933. The frequency is 
reportedly from 10.8 % to 15.5 % in advanced esophageal cancers [2, 3, 8, 9]. In this 
study, the incidence of IM was only 0.6 % in cases of resected gastric cancer and 1 % in 
advanced cancer cases, and was a very rare pathology, compared with the incidence in 
esophageal cancer. 
 Compared with primary lesions without IM in esophageal squamous cell 
carcinoma, the clinicopathological features of primary lesions with IM are reported to 
include: advanced stage grouping; higher rate of lymph node metastasis (79–99%); and 
a higher rate of capillary invasion (76–100%) [1–3, 9]; features that correspond to the 
results of this study in gastric cancer. Distant metastasis was detected in 37.9% of IM in 
this study, whereas the reported rate of IM is 29.2% in esophageal cancer [2].  
 It is believed that IM in esophageal cancer is mediated by lymphatic invasion 
to the submucosal layer. Consequently, it is believed that lymphatic invasion and/or 
lymph node metastasis cases are common, with large numbers of lymph node 
metastases [7]. In this study, based on the fact that cases positive for capillary invasion 
are common, particularly for lymphatic invasion, the proliferation of cancer cells deeper 
than the submucosal layer via lymph flow was also assumed to be an onset mechanism 
for IM in gastric cancer, similar to esophageal cancer. 
 In this study, the IM size was approximately within 2 cm, and many occurred 
within 2 cm of the primary lesion regarding. Multiple IMs were observed in 38 % of IM 
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cases and 31.0 % of IM cases had intramural metastasis outside the stomach. Some 
literature states that gastrointestinal endoscopy should be used first, because it is 
convenient and allows for histological examinations [10]. Especially for advanced 
gastric cancers, careful observation within 2 cm of the primary lesion and observation of 
adjacent organs for the presence of IM will be important for determining the line of 
dissection of the stomach. However, caution is required because there are cases in which 
IM is observed inside a wall that is relatively far from the primary lesion, at a maximum 
of 5.5 cm, or metastasis to the duodenum or the esophagus is observed.  
 Regarding the positional relationship between the primary lesion and the IM in 
esophageal cancers, Takubo et al. reported that IM was equally present on both sides of 
the primary lesion [2]. Similarly, in our study, IM was present equally on both sides. 
 In this study, the IM was detected preoperatively in 5 cases (17.2 %). All IMs 
existed in layers deeper than the sm, so submucosal tumors covered with normal 
epithelium are an important finding in gastrointestinal barium studies and endoscopic 
examinations. Takubo et al. [2] reported that the IM in esophageal cancer was detected 
preoperatively 54.2 % of the time with a dome-like appearance covered with normal 
epithelium, similar to that of submucosal tumors, often with erosion or ulceration. The 
difficulties in making a preoperative diagnosis of IM in gastric cancer are probably due 
to the small size and the absence of erosion and ulceration. 
 The prognosis of esophageal cancer accompanied by IM is exceedingly bad, 
with a survival rate at 5 years of 9 % and a median survival time of 7 months [3]; 
making it one of the major causes of poor postoperative prognosis [1, 2]. The median 
survival time of gastric cancer cases with IM was relatively favorable, at 11 months 
(13.9 % survival rate at 3 years). However, the results of our study indicated a 
11 
 
significantly poorer prognosis in all gastric cancers with IM than in cases of advanced 
gastric cancer without IM. A subgroup of cases with IM within 1 cm of the primary 
lesion had a relatively favorable prognosis in this study. Yuasa et al.[3] also reported 
that a subgroup of cases with IM less than 2.0 cm from the primary tumor may have a 
relatively favorable prognosis in esophageal cancer. More specifically, even if a gastric 
cancer is accompanied by IM, long-term survival may be achieved if curability can be 
obtained and if the IM remains in the vicinity of the primary lesion.  
 This study has several limitations. Because of the low overall number of cases 
diagnosed with IM in gastric cancer, the number of cases in our study was too small to 
perform more rigorous statistical evaluation, and bias may have affected the 
clinicopathological investigation. However, the method of histopathological evaluation 
was consistent, and this consistency can be considered a strong point of the study. 
 In conclusion, the presence of IM is thought to be one of the most important 
pathways of tumor spread and a factor in determining the prognosis of gastric cancer 
cases. In this study, 1 % of advanced gastric cancer cases had IM. If the IM is diagnosed 
preoperatively and curative resection is possible, aggressive resection should be 
performed. If the IM is not diagnosed preoperatively, surgical margins of at least 2 cm 
or more should be obtained.  
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Fig. 1  A case of gastric cancer with intramural metastasis 
X-ray examination (a) and gross appearance of the resected specimen;  (b, c) showing the  
primary tumor (arrowhead ) and  IM (arrow). The IM is clearly separated  
from the primary tumor and has the gross appearance of a submucosal tumor. 
IM (arrow) is present in the submucosal layer histologically (d), H & E. 
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Fig. 2 Postoperative survival  of IM cases 
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Fig. 3 Survival curves for patients with all gastric cancers with IM (n=29) and advanced gastric 
cancer without IM (n=2770),  p < 0.0001 
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 The majority of IMs were under 2 cm in size and located 
within 2 cm of the primary tumor. 
Fig. 5   Postoperative survival according to the distance from primary tumor 
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Fig. 6  Postoperative survival according to the size of the IM 
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